CMS: Medicare beneficiaries saved $3.9B on meds in 2013

CMS: medicare beneficiaries saved $3.9B on meds in 2013

(HealthDay)—In 2013, 4.3 million seniors and people with disabilities saved an estimated $3.9 billion on prescription drugs, an increase from the 2012 savings, according to a report published by the U.S. Department of Health and Human Services.

Since the enactment of the Affordable Care Act, 7.9 million seniors and people with disabilities have saved $9.9 billion on , equivalent to $1,265 per beneficiary. In 2013, 4.3 million beneficiaries saved $3.9 billion, equivalent to $911 per beneficiary, which represented an increase from 2012 when 3.5 million beneficiaries saved $2.5 billion, representing average savings of $706 per beneficiary.

As well as savings on prescription drugs, use of has increased among those with Medicare, with an estimated 37.2 million Medicare beneficiaries (including 26.5 million with traditional Medicare) taking advantage of at least one preventive service with no cost sharing in 2013. This included more than four million people who took advantage of the Annual Wellness Visit in 2013. These figures reflect an increase from 2012 when an estimated 34.1 million people with Medicare, including 26.1 with traditional Medicare, received one or more preventive benefit.

"Thanks to the Affordable Care Act, we saw a stronger Medicare program in 2013," Kathleen Sebelius, U.S. Secretary of Health and Human Services, said in a statement. "Seniors are saving billions of dollars on their needed medications and continuing to enjoy benefits that will lead to healthier lives and lower costs in the long run."

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

User comments